These factors were previously found to be independent predictors of breast cancer mortality: the mortality risk was 20–40-fold higher in patients with the worst prognosis than in those with tumors having smaller size, lower grade, and ER(+)/PR(+)/HER2(−) status26. This evidence concerns the gene ERBB2 and breast carcinoma.